Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.76 |
| ▸ | LPL | P06858 | 13/20 | 0.76 |
| ▸ | P4HB | P07237 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | F11 | P03951 | 2/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19046610 | 1.00 | LIPG (0.76) | LIPGLPLP4HBCA1CA2 | |
| Ammonia Solution, Strong SCHEMBL4385797 | 0.98 | LIPG (0.73) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL17783266 | 0.91 | LIPG (0.66) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL15743263 | 0.88 | LIPG (0.61) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL228212 | 0.87 | LPL (0.71) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL10021061 | 0.87 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL18270366 | 0.87 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL18134357 | 0.87 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL476870 | 0.87 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL22383015 | 0.86 | LIPG (0.65) | LIPGLPLP4HBCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1827 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2026-05-19 | — | — | US | claimed |
| US-20220263102-A1 | ELIMINATING VOLTAGE DELAY AND STABILIZING IMPEDANCE BY ELECTROLYTE ADDITIVES IN ALKALI METAL ELECTROCHEMICAL CELLS | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2022-08-18 | — | — | US | claimed |
| CN-113136020-B | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114605602-A | Hierarchical pore covalent organic framework compound and preparation method and application thereof | 浙江工业大学 | 2022-06-10 | — | — | CN | claimed |
| EP-3997748-A1 | ELIMINATION OF VOLTAGE DELAY AND STABILIZATION OF IMPEDANCE BY ELECTROLYTE ADDITIVES IN ALKALI METAL ELECTROCHEMICAL CELLS | LITRONIK Batterietechnologie GmbH (DE) | 2022-05-18 | — | — | EP | claimed |
| CN-114342141-A | Elimination of voltage delay and stabilization of impedance by electrolyte additives in alkali metal electrochemical cells | 利特罗尼克电池技术有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-10698121-B2 | 10B enriched plastic scintillators for application in thermal neutron detection, methods of making and using the same | SELLINGER ALAN (US) | 2020-06-30 | — | — | US | claimed |
| US-20190041533-A1 | 10B ENRICHED PLASTIC SCINTILLATORS FOR APPLICATION IN THERMAL NEUTRON DETECTION, METHODS OF MAKING AND USING THE SAME | SELLINGER ALAN (US) | 2019-02-07 | — | — | US | claimed |
| EP-2714660-B1 | NEPRILYSIN INHIBITORS | THERAVANCE BIOPHARMA R&D IP LLC (US) | 2018-09-26 | — | — | EP | claimed |
| CN-107074825-A | Benzyl substituted indazoles as BUB1 kinase inhibitors | 拜耳制药股份公司 | 2017-08-18 | — | — | CN | claimed |
| EP-3194381-A1 | BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2017-07-26 | — | — | EP | claimed |
| EP-3194380-A1 | BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2017-07-26 | — | — | EP | claimed |
| WO-2016042081-A1 | BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-03-24 | — | — | WO | claimed |
| WO-2016042080-A1 | BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-03-24 | — | — | WO | claimed |
| US-20120309724-A1 | NEPRILYSIN INHIBITORS | THERAVANCE, INC. (US) | 2012-12-06 | — | — | US | claimed |
| WO-2012166390-A1 | NEPRILYSIN INHIBITORS | THERAVANCE, INC. (US) | 2012-12-06 | — | — | WO | claimed |
| WO-2026104431-A1 | ORGANIC LIGHT-EMITTING DEVICE | MERCK PATENT GMBH (DE) | 2026-05-21 | — | — | WO | disclosed |
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | LITRONIK BATTERIETECHNOLOGIE GMBH (DE) | 2026-05-19 | — | — | US | disclosed |
| EP-1127060-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000027853-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309724-A1 | NEPRILYSIN INHIBITORS | MME, REN, ACE | LIPG 1062/4885LPL 1277/4885P4HB 4167/4885 |
| US-12633548-B2 | Eliminating voltage delay and stabilizing impedance by electrolyte additives in alkali metal electrochemical cells | KCNN1, HCN4, KCNN2 | LIPG 4122/4885LPL 4624/4885P4HB 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.